Linked Life Data

8903485

Source:http://linkedlifedata.com/resource/pubmed/id/8903485

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1996-12-5
pubmed:abstractText
Combinations of surgery and chemotherapy are crucial in the treatment of ovarian cancer. This article reviews the conclusions of all recently performed trials and gives information on the now open randomized studies. The importance of radical surgery in combination with chemotherapy in early disease is clear, but uncertainties still exist in relation to timing and choice of chemotherapy. Many data from trials are helpful in outlining the indications for cytoreductive surgery, the timing of this procedure, second-look laparotomy in clinically complete remission, and secondary cytoreduction, but many details are yet to be addressed in future randomized studies. The place of new chemotherapeutic agents (in advanced disease and in adjuvant setting) is currently being investigated in many clinical trials.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0748-7983
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
455-66
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Clinical trials in patients with epithelial ovarian cancer: past, present and future.
pubmed:affiliation
Department of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
pubmed:publicationType
Journal Article, Review